J. Frank Harmon serves as Executive at Abraxis BioScience, Inc., where they oversee executive responsibilities. Since joining the company, J. Frank Harmon has executed 6 insider transactions totaling $104.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 29, 2016 involved selling 8,915 shares valued at $193.9K.
J. Frank Harmon currently holds 8,915 shares of Abraxis BioScience, Inc. (ABBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. Frank Harmon has been a net seller of ABBI stock. They have purchased $0 and sold $104.3K worth of shares.
J. Frank Harmon's most recent insider trade was on Aug 29, 2016, when they sold 8,915 shares at $21.75 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 10, 2008 | APPX | $0 | Disposition | 15,812 | $N/A | Discretionary |
| Sep 10, 2008 | APPX | $0 | Disposition | 10,018 | $N/A | Discretionary |
| Aug 13, 2007 | ABBI | $104.3K | Sale | 5,000 | $20.85 | Discretionary |
| Dec 12, 2006 | ABBI | $0 | Award | 20,381 | $N/A | Discretionary |